Importance of Preoperative Knowledge of the Biomarker HE4 in Early-stage Endometrial Cancer Regarding Surgical Management.

MLA

Presl, Jiri, et al. “Importance of Preoperative Knowledge of the Biomarker HE4 in Early-Stage Endometrial Cancer Regarding Surgical Management.” Anticancer Research, vol. 37, no. 5, May 2017, pp. 2697–702. EBSCOhost, https://doi.org/10.21873/anticanres.11619.

APA

Presl, J., Ovesna, P., Novotny, Z., Vlasak, P., Bouda, J., Kostun, J., Topolcan, O., Kucera, R., Bednarikova, M., & Weinberger, V. (2017). Importance of Preoperative Knowledge of the Biomarker HE4 in Early-stage Endometrial Cancer Regarding Surgical Management. Anticancer Research, 37(5), 2697–2702. https://doi.org/10.21873/anticanres.11619

Chicago

Presl, Jiri, Petra Ovesna, Zdenek Novotny, Pavel Vlasak, Jiri Bouda, Jan Kostun, Ondrej Topolcan, Radek Kucera, Marketa Bednarikova, and Vit Weinberger. 2017. “Importance of Preoperative Knowledge of the Biomarker HE4 in Early-Stage Endometrial Cancer Regarding Surgical Management.” Anticancer Research 37 (5): 2697–2702. doi:10.21873/anticanres.11619.